Marché des immunothérapies contre les allergies – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00008219
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 149
Buy Now

Le marché des immunothérapies contre les allergies était évalué à 1 819,18 millions de dollars américains en 2019 et devrait atteindre 4 185,89 millions de dollars américains d'ici 2027 ; il devrait croître à un TCAC de 11,1 % de 2020 à 2027.



L'immunothérapie allergique, également appelée désensibilisation ou hypo-sensibilisation, est un traitement médical axé sur plusieurs types d'allergies. Il y a une augmentation de la prévalence des allergies et les interventions thérapeutiques conventionnelles, telles que la pharmacothérapie, se sont souvent révélées incompétentes. Par conséquent, l'immunothérapie antiallergique gagne en popularité pour guérir plusieurs types d'allergies en augmentant la tolérance immunologique et en modifiant l'évolution de la maladie. Le marché des immunothérapies contre les allergies devrait croître en raison de facteurs déterminants tels que la prévalence croissante des troubles allergiques et les progrès technologiques dans les formulations posologiques sublinguales. Cependant, les inconvénients associés à l'utilisation des immunothérapies contre les allergies et les variations réglementaires entre les régions sont susceptibles d'entraver la croissance du marché au cours de la période de prévision.



Régions lucratives pour le marché des immunothérapies contre les allergies



Marché Insights



Prévalence croissante des troubles allergiques



Les troubles allergiques sont les problèmes les plus courants traités par les médecins de premier recours et les pédiatres ; plus de 25% de la population des pays développés souffre d'allergies. Les allergies englobent un éventail de troubles caractérisés par le développement d'une réponse immunitaire hyperactive à un allergène, entraînant une réponse des cytokines polarisées Th2 à l'allergène et la production d'une réponse d'anticorps IgE.



La prévalence croissante de les troubles allergiques exigent une immunothérapie allergique, qui est un traitement sûr et efficace contre les allergènes tels que le pollen, les moisissures d'insectes et les animaux, ainsi que pour l'asthme allergique. Dans le récent rapport de l'enquête nationale sur la santé et la nutrition, 54% de la population avait des réponses positives à un ou plusieurs allergènes. Selon l'American Academy of Allergy, Asthma & En immunologie, la rhinite allergique touche 10 à 30 % de la population, et les effets indésirables des médicaments peuvent toucher jusqu'à 10 % de la population mondiale, et près de 20 % des patients hospitalisés. Selon les données de l'enquête du National Center for Health Statistics réalisée en 2018, le nombre d'allergies respiratoires, d'allergies alimentaires et d'allergies cutanées signalées au cours des 12 derniers mois était de 7,1 millions, 4,8 millions et 9,2 millions, respectivement.

L'immunothérapie est un traitement préventif des réactions allergiques à des substances telles que les acariens, le venin d'abeille et les pollens de graminées. L'immunothérapie implique une augmentation progressive des doses de l'allergène ou de la substance à laquelle le patient est allergique. Les doses incrémentielles de l'allergène rendent le système immunitaire moins sensible à la substance, probablement en induisant la production d'un anticorps « bloquant » ; cela réduit les symptômes allergiques lorsque la substance est rencontrée à l'avenir. L'immunothérapie réduit également l'inflammation qui caractérise l'asthme et la rhinite. Les troubles allergiques sont principalement traités par immunothérapie; ainsi, la prévalence croissante des maladies allergiques stimule la croissance du marché.



Aperçus basés sur le traitement



Le marché mondial des immunothérapies contre les allergies, basé sur le traitement, est segmenté en immunothérapie sous-cutanée (SCIT) et en immunothérapie sublinguale (SLIT). En 2019, le segment de l'immunothérapie sous-cutanée (SCIT) détenait la plus grande part de marché, par traitement. Cependant, le segment de l'immunothérapie sublinguale (ITSL) devrait croître au rythme le plus rapide au cours de la période de prévision.



Marché mondial des immunothérapies contre les allergies, par traitement - 2019 & 2027



Informations basées sur le type d'allergie



Le marché mondial des immunothérapies contre les allergies, basé sur le type d'allergie, a été segmenté en rhinite allergique, asthme, allergie alimentaire, allergie au venin et autres. Le segment de la rhinite allergique détenait la part la plus élevée du marché des immunothérapies allergiques en 2019, par type d'allergie. De plus, le même segment devrait connaître une croissance à un rythme significatif au cours de la période de prévision, de 2020 à 2027.



Distribution Channel -Based Insights



Marché mondial des immunothérapies contre les allergies, basé sur la distribution canal est segmenté en pharmacie hospitalière, pharmacie de détail et pharmacie en ligne. En 2019, le segment des pharmacies hospitalières détenait la plus grande part de marché, par canal de distribution. De plus, le même segment pharmaceutique devrait croître au rythme le plus rapide au cours de la période de prévision



Les lancements de produits et la stratégie d'expansion sont couramment adoptés par les entreprises pour étendre leur présence dans le monde et répondre à la demande croissante. Ces stratégies sont couramment adoptées par les acteurs du marché afin d'élargir leur portefeuille de produits.



Les acteurs du marché opérant sur le marché des immunothérapies allergiques ont adopté la stratégie d'innovation produit pour répondre à l'évolution de la demande des clients à travers le monde, ce qui permet également aux joueurs de conserver leur marque à l'échelle mondiale.



Par traitement




  • Immunothérapie sous-cutanée (SCIT)

  • Immunothérapie sublinguale (SLIT)

Par type d'allergie




  • Rhinite allergique

  • Asthme

  • Allergie alimentaire

  • Allergie au venin< /li>
  • Autres


Par canal de distribution




  • Pharmacie hospitalière

  • Pharmacie de détail

  • En ligne Pharmacie


Par géographie




  • Amérique du Nord

    • États-Unis

    • Canada

    • Mexique< /li>


  • Europe

    • France

    • Allemagne

    • Italie

    • Royaume-Uni

    • Espagne



  • Asie-Pacifique (APAC)

    • Chine

    • Inde

    • Corée du Sud
    • Japon

    • Australie



  • Moyen-Orient & ; Afrique (MEA)

    • Afrique du Sud

    • Arabie saoudite

    • EAU



  • Amérique du Sud (SAM)< ul>
  • Brésil

  • Argentine




Profils des entreprises




  • ALK-Abelló A/S

  • AIMMUNE THERAPEUTICS, INC.

  • LETIPharma

  • Stallergenes Greer

  • HAL Allergy BV

  • Johnson et Johnson Services, Inc.

  • Anergis

  • DBV Technologies

  • Dermapharm Holding

  • Thérapeutique contre les allergies


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the allergy immunotherapies market?

The allergy immunotherapy market majorly consists of the players such as ALK-Abelló A/S, AIMMUNE THERAPEUTICS, INC., LETIPharma, Stallergenes Greer, HAL Allergy B.V., Anergis, DBV Technologies, Dermapharm Holding, Allergy Therapeutics, ASIT biotech are among others.

What are the driving factors for the allergy immunotherapies market across the globe?

The factors that are driving the growth of the market are increasing prevalence of allergic disorders and rising preference for immunotherapies due to efficacy and cost-effectiveness are expected to boost the growth of the global allergy immunotherapy market.

What is allergy Immunotherapy?

Allergy Immunotherapy is an allergy treatment process that involves administering small quantities of allergens into your body and then building up doses slowly over some time until the patient develops immunity. Two types of immunotherapy therapies are available in the market, such as subcutaneous immunotherapy (SCIT), also called allergy shots, and sublingual immunotherapy (SLIT). Individuals with symptoms of allergy and do not respond to conventional medical treatments are the potential targets for allergen immunotherapy.

The List of Companies - Allergy Immunotherapies Market

  1. ALK-Abelló A/S
  2. AIMMUNE THERAPEUTICS, INC.
  3. LETIPharma
  4. Stallergenes Greer
  5. HAL Allergy B.V.
  6. Johnson and Johnson Services, Inc.
  7. Anergis
  8. DBV Technologies
  9. Dermapharm Holding
  10. Allergy Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports